Ken Fisher Jazz Pharmaceuticals PLC Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2023	BUY	$122.5 - $147.16 $1.21 Million - $1.45 Million	9,861 New	9,861 $1.22 Million
Q2 2023 Aug 08, 2023	SELL	$122.5 - $147.16 $14,332 - $17,217	-117 Reduced 1.17%	9,861 $1.22 Million
Q1 2023 Dec 12, 2023	BUY	$133.98 - $160.47 $1.32 Million - $1.58 Million	9,861 New	9,861 $1.44 Million
Q1 2023 May 01, 2023	SELL	$133.98 - $160.47 $3,081 - $3,690	-23 Reduced 0.23%	9,978 $1.46 Million
Q4 2022 Feb 03, 2023	BUY	$129.72 - $159.85 $1.3 Million - $1.6 Million	10,001 New	10,001 $1.59 Million
Q1 2018 Apr 19, 2018	BUY	$135.59 - $157.16 $816,116 - $945,946	6,019 Added 374.78%	7,625 $1.15 Million
Q3 2017 Oct 17, 2017	BUY	$142.62 - $155.6 $229,047 - $249,893	1,606	1,606 $235,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.